Lv0
0 积分 2025-08-15 加入
乳腺癌PAM通路抑制剂不良反应管理专家共识（2026版）
3小时前
待确认
GSTA1 conferred tolerance to osimertinib and provided strategies to overcome drug-tolerant persister in EGFR-mutant lung adenocarcinoma
6个月前
已完结
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
8个月前
已完结
The Status and Future Directions of Treatments for Polyglutamine Spinocerebellar Ataxia: A Bibliometric and Visual Analysis
9个月前
已完结
皖公网安备34019202002308
